Ayahuasca has been used as a medicine in Mesoamerican ceremonies for thousands of years, but the primary psychoactive compound, DMT, was not synthesised until 1931. DMT was studied during the wave of psychedelic research in the 1950s and 60s until research was banned in 1971 by the Convention of Psychotropic Substances. Ayahuasca was not included …
In this seminar, Professor Barnes provides a walkthrough of how to prescribe medical cannabis under the current UK regulations and the future of prescribing in the UK. 2020 was a turbulent year in which all resemblance of ‘normality’ was morphed into the ‘new normal’. This has also impacted the way in which prescriptions are made …
We are now recruiting Honorary Research Assistants to join our team. We are in an exciting stage of growth as an organisation and have several opportunities to contribute to existing and developing research projects. This includes (but is not limited to) helping with literature reviews, data collection, data analysis and publications. Please note, as this …
MDMA (3,4-Methylenedioxymethamphetamine) was first synthesised in 1912 by chemists at the pharmaceutical company, Merck in Germany. In 1985, MDMA was placed in schedule 1, resulting in no research being conducted into the potential therapeutic applications of MDMA between 1985 – 2000. However, since then, MDMA has been included in over 5000 academic articles and administered to …
The psychotropic effects of Psilocybe mushrooms were largely unknown in the West until the 1950s, despite evidence that they had a long history of indigenous use in Central and South America, and possibly other parts of the world. Western civilisations had very little knowledge of this relatively ‘new‘ psychotropic and subsequently banned research into its …
Calling all students! Drug Science is very excited to announce the launch of the Drug Science Student Society. The Drug Science Student Society is a student-led group which aims to provide evidence-based education on all psychoactive substances. Historically, political interference has prevented evidence-based drug policy from guiding decisions in law, social care and medicine. Drug …
On the 1st of November 2018, medicinal cannabis products were removed from schedule 1 and placed in schedule 2 of the Misuse of Drugs Regulations 2001. This change in the law has left patients, medical professionals and law enforcement perplexed about who should and who should not have access to medicinal cannabis. As access …